These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24646734)

  • 21. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.
    Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW
    J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
    Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
    J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.
    Johnson TA; Evans BL; Durafourt BA; Blain M; Lapierre Y; Bar-Or A; Antel JP
    J Immunol; 2011 Jul; 187(1):570-9. PubMed ID: 21622858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
    Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
    J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells.
    Wendt K; Wilk E; Buyny S; Buer J; Schmidt RE; Jacobs R
    J Leukoc Biol; 2006 Dec; 80(6):1529-41. PubMed ID: 16966385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells.
    Vukicevic M; Chalandon Y; Helg C; Matthes T; Dantin C; Huard B; Chizzolini C; Passweg J; Roosnek E
    Eur J Immunol; 2010 Nov; 40(11):3246-54. PubMed ID: 20957748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
    Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D
    J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD; Daley J; Ritz J; Robertson MJ
    J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone-induced blocking factor inhibits degranulation of natural killer cells.
    Faust Z; Laskarin G; Rukavina D; Szekeres-Bartho J
    Am J Reprod Immunol; 1999 Aug; 42(2):71-5. PubMed ID: 10476687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
    Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
    J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD27 defines phenotypically and functionally different human NK cell subsets.
    Vossen MT; Matmati M; Hertoghs KM; Baars PA; Gent MR; Leclercq G; Hamann J; Kuijpers TW; van Lier RA
    J Immunol; 2008 Mar; 180(6):3739-45. PubMed ID: 18322179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
    Bauernhofer T; Kuss I; Henderson B; Baum AS; Whiteside TL
    Eur J Immunol; 2003 Jan; 33(1):119-24. PubMed ID: 12594840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosenescence of human natural killer cells.
    Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
    J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
    Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
    J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD56bright natural killer (NK) cells: an important NK cell subset.
    Poli A; Michel T; Thérésine M; Andrès E; Hentges F; Zimmer J
    Immunology; 2009 Apr; 126(4):458-65. PubMed ID: 19278419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.
    Grom AA; Villanueva J; Lee S; Goldmuntz EA; Passo MH; Filipovich A
    J Pediatr; 2003 Mar; 142(3):292-6. PubMed ID: 12640378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.